Amoco Corporation

Vysis, Inc.

Dale A Pelletier

William G Weisburg

Susan M Barns

Mitchell L Sogin

Nucleic acids having approximately 10 to 250 nucleotides which are capable of hybridizing to rRNA and RDNA of mycoplasma etiological agents of nongonococcal urethritis, pelvic inflammatory disease, salpingiuis, and other infections due to mycoplasmas from the genital areas, , and

Nucleic acid probes for the detection of genital mycoplasmas

Nucleic acids having approximately 10 to 250 nucleotides which are capable of hybridizing to rRNA and rDNA of mycoplasma etiological agents of nongonococcal urethritis, pelvic inflammatory disease, salpingitis, and other infections due to mycoplasmas from the genital areas, Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum.

Nucleic acid probes for the detection for genital mycoplasmas

Nucleic acid sequences which hybridize preferentially to the 16S or 23S rRNA or rDNA of Legionella sp., L. pneumophila, L. micdadei, a L. pneumophila, or a Legionella subset are taught. These organisms are the etiological agents of Legionnaires' disease, Pontiac fever, Pittsburgh pneumonia and other infections. The nucleic acids are useful in the detection of these pathogenic microorganisms. Probes based on these sequences and kits containing the probes are also disclosed.

Nucleic acid probes for the detection of bacteria of the genus

Nucleic acid probes are described for detecting the principle etiological agent of primary atypical pneumonia, Mycoplasma pneumoniae, or, optionally, Mycoplasma pneumoniae and Mycoplasma genitalium. Said probes are complementary to ribonucleic acid sequences found in these mycoplasmas and absent from other mycoplasma, other bacterial, animal, or plant genomes. As such, these probes can detect the rRNA, rDNA, or polymerase chain reaction amplification products from these mycoplasma species. This set of probes, plus the described amplification primers, circumscribe a method for detecting the etiological agents of atypical pneumonia, and for making a clinical diagnosis of this disease. This set of probes also circumscribes a method for identification of these infectious agents in culture media enrichments inoculated from clinical samples.

Nucleic acid probes for the detection of mycoplasma pneumoniae and

Nucleic acid probes are described for detecting fungi capable of causing fungal septicemia or capable of causing food spoilage. The preferred probes are complementary to ribonucleic acid sequences found in numerous fungi and absent in animal or plant genomes. As such, these probes can detect the rRNA, rDNA, or polymerase chain reaction amplification products from the majority of fungal species. The detection of etiological agents of human fungemia, the clinical diagnosis of this disease and the direct evaluation of food or beverage fungal content utilizing rRNA or rDNA probes is now possible.

Growing community of inventors

Brighton, MA, United States of America

Dale A Pelletier